nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—breast cancer	0.448	0.672	CbGaD
Pentosan Polysulfate—FGF1—breast cancer	0.219	0.328	CbGaD
Pentosan Polysulfate—FGF4—embryo—breast cancer	0.0074	0.16	CbGeAlD
Pentosan Polysulfate—FGF4—female reproductive system—breast cancer	0.00448	0.0969	CbGeAlD
Pentosan Polysulfate—FGF2—mammary gland—breast cancer	0.00385	0.0833	CbGeAlD
Pentosan Polysulfate—FGF4—endocrine gland—breast cancer	0.00379	0.082	CbGeAlD
Pentosan Polysulfate—FGF1—mammary gland—breast cancer	0.00286	0.0619	CbGeAlD
Pentosan Polysulfate—FGF1—embryo—breast cancer	0.00195	0.0423	CbGeAlD
Pentosan Polysulfate—FGF2—endometrium—breast cancer	0.00192	0.0416	CbGeAlD
Pentosan Polysulfate—FGF2—uterus—breast cancer	0.00177	0.0383	CbGeAlD
Pentosan Polysulfate—FGF2—pituitary gland—breast cancer	0.00174	0.0376	CbGeAlD
Pentosan Polysulfate—FGF2—adipose tissue—breast cancer	0.00173	0.0375	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—breast cancer	0.00159	0.0345	CbGeAlD
Pentosan Polysulfate—FGF2—adrenal gland—breast cancer	0.00155	0.0336	CbGeAlD
Pentosan Polysulfate—FGF1—skin of body—breast cancer	0.00152	0.0328	CbGeAlD
Pentosan Polysulfate—FGF2—female gonad—breast cancer	0.00145	0.0313	CbGeAlD
Pentosan Polysulfate—FGF1—pituitary gland—breast cancer	0.00129	0.028	CbGeAlD
Pentosan Polysulfate—FGF1—adipose tissue—breast cancer	0.00129	0.0279	CbGeAlD
Pentosan Polysulfate—FGF1—female reproductive system—breast cancer	0.00118	0.0256	CbGeAlD
Pentosan Polysulfate—FGF1—adrenal gland—breast cancer	0.00116	0.025	CbGeAlD
Pentosan Polysulfate—FGF1—female gonad—breast cancer	0.00108	0.0233	CbGeAlD
Pentosan Polysulfate—FGF1—endocrine gland—breast cancer	0.001	0.0217	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—breast cancer	0.000932	0.0201	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—breast cancer	0.000693	0.015	CbGeAlD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—breast cancer	5.5e-05	0.000438	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Docetaxel—breast cancer	5.49e-05	0.000438	CcSEcCtD
Pentosan Polysulfate—Anaemia—Capecitabine—breast cancer	5.49e-05	0.000438	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—breast cancer	5.49e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—breast cancer	5.43e-05	0.000432	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—breast cancer	5.42e-05	0.000432	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—breast cancer	5.41e-05	0.000431	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—breast cancer	5.4e-05	0.00043	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Paclitaxel—breast cancer	5.38e-05	0.000429	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—breast cancer	5.37e-05	0.000428	CcSEcCtD
Pentosan Polysulfate—Malaise—Capecitabine—breast cancer	5.36e-05	0.000427	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—breast cancer	5.35e-05	0.000427	CcSEcCtD
Pentosan Polysulfate—Insomnia—Paclitaxel—breast cancer	5.34e-05	0.000426	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—breast cancer	5.34e-05	0.000425	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Irinotecan—breast cancer	5.34e-05	0.000425	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Mitoxantrone—breast cancer	5.34e-05	0.000425	CcSEcCtD
Pentosan Polysulfate—Vomiting—Thiotepa—breast cancer	5.33e-05	0.000425	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Capecitabine—breast cancer	5.32e-05	0.000424	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Paclitaxel—breast cancer	5.31e-05	0.000423	CcSEcCtD
Pentosan Polysulfate—Rash—Thiotepa—breast cancer	5.29e-05	0.000422	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Thiotepa—breast cancer	5.29e-05	0.000421	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Paclitaxel—breast cancer	5.27e-05	0.00042	CcSEcCtD
Pentosan Polysulfate—Headache—Thiotepa—breast cancer	5.26e-05	0.000419	CcSEcCtD
Pentosan Polysulfate—Myalgia—Docetaxel—breast cancer	5.22e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Docetaxel—breast cancer	5.22e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Nausea—Vinorelbine—breast cancer	5.22e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Paclitaxel—breast cancer	5.2e-05	0.000415	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—breast cancer	5.16e-05	0.000411	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—breast cancer	5.16e-05	0.000411	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—breast cancer	5.15e-05	0.00041	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Paclitaxel—breast cancer	5.14e-05	0.000409	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Fluorouracil—breast cancer	5.11e-05	0.000407	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—breast cancer	5.08e-05	0.000405	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—breast cancer	5.08e-05	0.000405	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Capecitabine—breast cancer	5.06e-05	0.000403	CcSEcCtD
Pentosan Polysulfate—Myalgia—Capecitabine—breast cancer	5.06e-05	0.000403	CcSEcCtD
Pentosan Polysulfate—Constipation—Paclitaxel—breast cancer	5.05e-05	0.000403	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—breast cancer	5.05e-05	0.000403	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—breast cancer	5.04e-05	0.000402	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—breast cancer	5.02e-05	0.0004	CcSEcCtD
Pentosan Polysulfate—Oedema—Docetaxel—breast cancer	5.01e-05	0.000399	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—breast cancer	5e-05	0.000399	CcSEcCtD
Pentosan Polysulfate—Discomfort—Capecitabine—breast cancer	5e-05	0.000398	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—breast cancer	5e-05	0.000398	CcSEcCtD
Pentosan Polysulfate—Pruritus—Gemcitabine—breast cancer	4.99e-05	0.000398	CcSEcCtD
Pentosan Polysulfate—Nausea—Thiotepa—breast cancer	4.98e-05	0.000397	CcSEcCtD
Pentosan Polysulfate—Infection—Docetaxel—breast cancer	4.98e-05	0.000397	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—breast cancer	4.97e-05	0.000396	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—breast cancer	4.97e-05	0.000396	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Irinotecan—breast cancer	4.96e-05	0.000395	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mitoxantrone—breast cancer	4.96e-05	0.000395	CcSEcCtD
Pentosan Polysulfate—Pruritus—Fluorouracil—breast cancer	4.91e-05	0.000391	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Docetaxel—breast cancer	4.9e-05	0.000391	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Paclitaxel—breast cancer	4.87e-05	0.000388	CcSEcCtD
Pentosan Polysulfate—Oedema—Capecitabine—breast cancer	4.85e-05	0.000386	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Paclitaxel—breast cancer	4.83e-05	0.000385	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Gemcitabine—breast cancer	4.83e-05	0.000385	CcSEcCtD
Pentosan Polysulfate—Infection—Capecitabine—breast cancer	4.82e-05	0.000384	CcSEcCtD
Pentosan Polysulfate—Dizziness—Irinotecan—breast cancer	4.79e-05	0.000382	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—breast cancer	4.78e-05	0.000381	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—breast cancer	4.78e-05	0.000381	CcSEcCtD
Pentosan Polysulfate—Anorexia—Docetaxel—breast cancer	4.77e-05	0.00038	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—breast cancer	4.77e-05	0.00038	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—breast cancer	4.76e-05	0.00038	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Fluorouracil—breast cancer	4.75e-05	0.000378	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Capecitabine—breast cancer	4.75e-05	0.000378	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—breast cancer	4.74e-05	0.000378	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—breast cancer	4.72e-05	0.000376	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—breast cancer	4.7e-05	0.000374	CcSEcCtD
Pentosan Polysulfate—Urticaria—Paclitaxel—breast cancer	4.69e-05	0.000374	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Capecitabine—breast cancer	4.69e-05	0.000374	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—breast cancer	4.67e-05	0.000372	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Paclitaxel—breast cancer	4.67e-05	0.000372	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—breast cancer	4.62e-05	0.000368	CcSEcCtD
Pentosan Polysulfate—Anorexia—Capecitabine—breast cancer	4.62e-05	0.000368	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mitoxantrone—breast cancer	4.61e-05	0.000367	CcSEcCtD
Pentosan Polysulfate—Vomiting—Irinotecan—breast cancer	4.61e-05	0.000367	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—breast cancer	4.6e-05	0.000366	CcSEcCtD
Pentosan Polysulfate—Dizziness—Fluorouracil—breast cancer	4.59e-05	0.000366	CcSEcCtD
Pentosan Polysulfate—Rash—Mitoxantrone—breast cancer	4.57e-05	0.000364	CcSEcCtD
Pentosan Polysulfate—Rash—Irinotecan—breast cancer	4.57e-05	0.000364	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mitoxantrone—breast cancer	4.56e-05	0.000364	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Irinotecan—breast cancer	4.56e-05	0.000364	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Docetaxel—breast cancer	4.56e-05	0.000364	CcSEcCtD
Pentosan Polysulfate—Headache—Irinotecan—breast cancer	4.54e-05	0.000362	CcSEcCtD
Pentosan Polysulfate—Headache—Mitoxantrone—breast cancer	4.54e-05	0.000362	CcSEcCtD
Pentosan Polysulfate—Insomnia—Docetaxel—breast cancer	4.53e-05	0.000361	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Docetaxel—breast cancer	4.5e-05	0.000358	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—breast cancer	4.49e-05	0.000358	CcSEcCtD
Pentosan Polysulfate—Vomiting—Gemcitabine—breast cancer	4.49e-05	0.000358	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Docetaxel—breast cancer	4.47e-05	0.000356	CcSEcCtD
Pentosan Polysulfate—Rash—Gemcitabine—breast cancer	4.45e-05	0.000355	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Gemcitabine—breast cancer	4.45e-05	0.000354	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—breast cancer	4.43e-05	0.000353	CcSEcCtD
Pentosan Polysulfate—Headache—Gemcitabine—breast cancer	4.42e-05	0.000352	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Capecitabine—breast cancer	4.42e-05	0.000352	CcSEcCtD
Pentosan Polysulfate—Vomiting—Fluorouracil—breast cancer	4.41e-05	0.000352	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—breast cancer	4.41e-05	0.000352	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Docetaxel—breast cancer	4.41e-05	0.000351	CcSEcCtD
Pentosan Polysulfate—Insomnia—Capecitabine—breast cancer	4.39e-05	0.00035	CcSEcCtD
Pentosan Polysulfate—Rash—Fluorouracil—breast cancer	4.38e-05	0.000349	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Fluorouracil—breast cancer	4.37e-05	0.000348	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—breast cancer	4.37e-05	0.000348	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Capecitabine—breast cancer	4.35e-05	0.000347	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Docetaxel—breast cancer	4.35e-05	0.000347	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Paclitaxel—breast cancer	4.35e-05	0.000347	CcSEcCtD
Pentosan Polysulfate—Headache—Fluorouracil—breast cancer	4.35e-05	0.000346	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Capecitabine—breast cancer	4.32e-05	0.000345	CcSEcCtD
Pentosan Polysulfate—Nausea—Mitoxantrone—breast cancer	4.3e-05	0.000343	CcSEcCtD
Pentosan Polysulfate—Nausea—Irinotecan—breast cancer	4.3e-05	0.000343	CcSEcCtD
Pentosan Polysulfate—Constipation—Docetaxel—breast cancer	4.28e-05	0.000341	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Capecitabine—breast cancer	4.27e-05	0.00034	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Capecitabine—breast cancer	4.22e-05	0.000336	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—breast cancer	4.2e-05	0.000335	CcSEcCtD
Pentosan Polysulfate—Nausea—Gemcitabine—breast cancer	4.19e-05	0.000334	CcSEcCtD
Pentosan Polysulfate—Pruritus—Paclitaxel—breast cancer	4.18e-05	0.000333	CcSEcCtD
Pentosan Polysulfate—Constipation—Capecitabine—breast cancer	4.15e-05	0.00033	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Docetaxel—breast cancer	4.13e-05	0.000329	CcSEcCtD
Pentosan Polysulfate—Nausea—Fluorouracil—breast cancer	4.12e-05	0.000329	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—breast cancer	4.1e-05	0.000327	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—breast cancer	4.1e-05	0.000327	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Docetaxel—breast cancer	4.1e-05	0.000326	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—breast cancer	4.09e-05	0.000326	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—breast cancer	4.08e-05	0.000325	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Paclitaxel—breast cancer	4.04e-05	0.000322	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Capecitabine—breast cancer	4e-05	0.000318	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—breast cancer	3.99e-05	0.000318	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Capecitabine—breast cancer	3.97e-05	0.000316	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Docetaxel—breast cancer	3.96e-05	0.000316	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—breast cancer	3.96e-05	0.000316	CcSEcCtD
Pentosan Polysulfate—Dizziness—Paclitaxel—breast cancer	3.91e-05	0.000311	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—breast cancer	3.89e-05	0.00031	CcSEcCtD
Pentosan Polysulfate—Urticaria—Capecitabine—breast cancer	3.85e-05	0.000307	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—breast cancer	3.84e-05	0.000306	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Capecitabine—breast cancer	3.83e-05	0.000306	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—breast cancer	3.83e-05	0.000305	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—breast cancer	3.8e-05	0.000303	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—breast cancer	3.77e-05	0.000301	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—breast cancer	3.77e-05	0.0003	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—breast cancer	3.77e-05	0.0003	CcSEcCtD
Pentosan Polysulfate—Vomiting—Paclitaxel—breast cancer	3.76e-05	0.000299	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—breast cancer	3.73e-05	0.000297	CcSEcCtD
Pentosan Polysulfate—Rash—Paclitaxel—breast cancer	3.73e-05	0.000297	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Paclitaxel—breast cancer	3.72e-05	0.000297	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—breast cancer	3.72e-05	0.000297	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—breast cancer	3.71e-05	0.000295	CcSEcCtD
Pentosan Polysulfate—Headache—Paclitaxel—breast cancer	3.7e-05	0.000295	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Docetaxel—breast cancer	3.69e-05	0.000294	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—breast cancer	3.59e-05	0.000286	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Capecitabine—breast cancer	3.57e-05	0.000285	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—breast cancer	3.55e-05	0.000283	CcSEcCtD
Pentosan Polysulfate—Pruritus—Docetaxel—breast cancer	3.54e-05	0.000282	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—breast cancer	3.54e-05	0.000282	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—breast cancer	3.53e-05	0.000282	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—breast cancer	3.52e-05	0.000281	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—breast cancer	3.52e-05	0.000281	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—breast cancer	3.52e-05	0.000281	CcSEcCtD
Pentosan Polysulfate—Nausea—Paclitaxel—breast cancer	3.51e-05	0.00028	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—breast cancer	3.49e-05	0.000278	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—breast cancer	3.48e-05	0.000277	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—breast cancer	3.45e-05	0.000275	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—breast cancer	3.44e-05	0.000274	CcSEcCtD
Pentosan Polysulfate—Pruritus—Capecitabine—breast cancer	3.43e-05	0.000273	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—breast cancer	3.43e-05	0.000273	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Docetaxel—breast cancer	3.43e-05	0.000273	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—breast cancer	3.38e-05	0.000269	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—breast cancer	3.36e-05	0.000267	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Capecitabine—breast cancer	3.32e-05	0.000264	CcSEcCtD
Pentosan Polysulfate—Dizziness—Docetaxel—breast cancer	3.31e-05	0.000264	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—breast cancer	3.31e-05	0.000264	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—breast cancer	3.29e-05	0.000262	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—breast cancer	3.27e-05	0.00026	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—breast cancer	3.27e-05	0.00026	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—breast cancer	3.26e-05	0.00026	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—breast cancer	3.26e-05	0.00026	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—breast cancer	3.24e-05	0.000258	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—breast cancer	3.22e-05	0.000257	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—breast cancer	3.22e-05	0.000257	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—breast cancer	3.22e-05	0.000256	CcSEcCtD
Pentosan Polysulfate—Dizziness—Capecitabine—breast cancer	3.21e-05	0.000256	CcSEcCtD
Pentosan Polysulfate—Vomiting—Docetaxel—breast cancer	3.18e-05	0.000254	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—breast cancer	3.18e-05	0.000253	CcSEcCtD
Pentosan Polysulfate—Rash—Docetaxel—breast cancer	3.16e-05	0.000252	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Docetaxel—breast cancer	3.16e-05	0.000251	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—breast cancer	3.14e-05	0.00025	CcSEcCtD
Pentosan Polysulfate—Headache—Docetaxel—breast cancer	3.14e-05	0.00025	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—breast cancer	3.13e-05	0.000249	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—breast cancer	3.11e-05	0.000247	CcSEcCtD
Pentosan Polysulfate—Vomiting—Capecitabine—breast cancer	3.08e-05	0.000246	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—breast cancer	3.08e-05	0.000245	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—breast cancer	3.06e-05	0.000244	CcSEcCtD
Pentosan Polysulfate—Rash—Capecitabine—breast cancer	3.06e-05	0.000244	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—breast cancer	3.06e-05	0.000244	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Capecitabine—breast cancer	3.05e-05	0.000243	CcSEcCtD
Pentosan Polysulfate—Headache—Capecitabine—breast cancer	3.04e-05	0.000242	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—breast cancer	3.03e-05	0.000242	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—breast cancer	3.02e-05	0.000241	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—breast cancer	3.01e-05	0.00024	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—breast cancer	2.98e-05	0.000237	CcSEcCtD
Pentosan Polysulfate—Nausea—Docetaxel—breast cancer	2.98e-05	0.000237	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—breast cancer	2.97e-05	0.000237	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—breast cancer	2.97e-05	0.000237	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—breast cancer	2.95e-05	0.000235	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—breast cancer	2.94e-05	0.000234	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—breast cancer	2.89e-05	0.00023	CcSEcCtD
Pentosan Polysulfate—Nausea—Capecitabine—breast cancer	2.88e-05	0.00023	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methotrexate—breast cancer	2.87e-05	0.000229	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—breast cancer	2.85e-05	0.000227	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.85e-05	0.000227	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—breast cancer	2.83e-05	0.000225	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—breast cancer	2.81e-05	0.000224	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—breast cancer	2.79e-05	0.000222	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—breast cancer	2.78e-05	0.000222	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—breast cancer	2.76e-05	0.00022	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—breast cancer	2.75e-05	0.000219	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—breast cancer	2.72e-05	0.000217	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—breast cancer	2.68e-05	0.000214	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—breast cancer	2.67e-05	0.000213	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—breast cancer	2.67e-05	0.000213	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—breast cancer	2.66e-05	0.000212	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—breast cancer	2.58e-05	0.000205	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—breast cancer	2.56e-05	0.000204	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—breast cancer	2.55e-05	0.000204	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—breast cancer	2.49e-05	0.000198	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—breast cancer	2.48e-05	0.000198	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—breast cancer	2.47e-05	0.000197	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—breast cancer	2.47e-05	0.000197	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—breast cancer	2.39e-05	0.00019	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—breast cancer	2.39e-05	0.00019	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—breast cancer	2.31e-05	0.000184	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—breast cancer	2.3e-05	0.000184	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—breast cancer	2.3e-05	0.000183	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—breast cancer	2.28e-05	0.000181	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—breast cancer	2.27e-05	0.000181	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—breast cancer	2.26e-05	0.00018	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—breast cancer	2.23e-05	0.000178	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—breast cancer	2.21e-05	0.000176	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—breast cancer	2.15e-05	0.000171	CcSEcCtD
Pentosan Polysulfate—Nausea—Methotrexate—breast cancer	2.14e-05	0.000171	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—breast cancer	2.14e-05	0.00017	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—breast cancer	2.13e-05	0.00017	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—breast cancer	2.13e-05	0.00017	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—breast cancer	2.12e-05	0.000169	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—breast cancer	2.07e-05	0.000165	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—breast cancer	2.01e-05	0.00016	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—breast cancer	1.99e-05	0.000158	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—breast cancer	1.97e-05	0.000157	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—breast cancer	1.97e-05	0.000157	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—breast cancer	1.96e-05	0.000156	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—breast cancer	1.86e-05	0.000148	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling Pathways—H2AFX—breast cancer	3.91e-06	2.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT2—breast cancer	3.89e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—breast cancer	3.89e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—E2F1—breast cancer	3.88e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—breast cancer	3.88e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS3—breast cancer	3.87e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CB—breast cancer	3.87e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MTOR—breast cancer	3.87e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—breast cancer	3.87e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD4—breast cancer	3.87e-06	2.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—breast cancer	3.86e-06	2.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—breast cancer	3.79e-06	2.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR1—breast cancer	3.77e-06	2.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—breast cancer	3.75e-06	2.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CD—breast cancer	3.74e-06	2.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—breast cancer	3.74e-06	2.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SPP1—breast cancer	3.73e-06	2.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—breast cancer	3.72e-06	2.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—breast cancer	3.71e-06	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—breast cancer	3.71e-06	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1B—breast cancer	3.7e-06	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SERPINE1—breast cancer	3.7e-06	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—breast cancer	3.7e-06	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB3—breast cancer	3.69e-06	2.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR2—breast cancer	3.69e-06	2.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—breast cancer	3.68e-06	2.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—breast cancer	3.68e-06	2.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—RAF1—breast cancer	3.66e-06	2.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNG—breast cancer	3.65e-06	2.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1B—breast cancer	3.64e-06	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—breast cancer	3.63e-06	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—breast cancer	3.63e-06	2.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—breast cancer	3.62e-06	2.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—breast cancer	3.62e-06	2.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LEP—breast cancer	3.62e-06	2.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RAF1—breast cancer	3.62e-06	2.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RELA—breast cancer	3.6e-06	2.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—breast cancer	3.6e-06	2.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—breast cancer	3.59e-06	2.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CAV1—breast cancer	3.59e-06	2.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—breast cancer	3.58e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CB—breast cancer	3.58e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTOR—breast cancer	3.58e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1B—breast cancer	3.57e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD4—breast cancer	3.57e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—breast cancer	3.56e-06	2.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—breast cancer	3.55e-06	2.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—breast cancer	3.55e-06	2.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—breast cancer	3.54e-06	2.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—breast cancer	3.54e-06	2.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS3—breast cancer	3.53e-06	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—breast cancer	3.53e-06	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MTOR—breast cancer	3.53e-06	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CB—breast cancer	3.53e-06	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD4—breast cancer	3.53e-06	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—breast cancer	3.53e-06	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—breast cancer	3.5e-06	2.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—breast cancer	3.46e-06	2.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—breast cancer	3.46e-06	2.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—breast cancer	3.44e-06	2.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR1—breast cancer	3.44e-06	2.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—breast cancer	3.44e-06	2.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—breast cancer	3.43e-06	2.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—breast cancer	3.43e-06	2.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—breast cancer	3.42e-06	2.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—breast cancer	3.42e-06	2.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—breast cancer	3.42e-06	2.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FN1—breast cancer	3.42e-06	2.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—breast cancer	3.41e-06	2.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—breast cancer	3.38e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NFKBIA—breast cancer	3.38e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1B—breast cancer	3.36e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—breast cancer	3.36e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—breast cancer	3.35e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—breast cancer	3.35e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOTCH1—breast cancer	3.34e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RAF1—breast cancer	3.34e-06	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK8—breast cancer	3.34e-06	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1B—breast cancer	3.32e-06	2.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—breast cancer	3.31e-06	2.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—breast cancer	3.31e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LEP—breast cancer	3.3e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—breast cancer	3.29e-06	2.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—breast cancer	3.28e-06	2.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK8—breast cancer	3.27e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—breast cancer	3.27e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CAV1—breast cancer	3.27e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—breast cancer	3.27e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—breast cancer	3.27e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—breast cancer	3.27e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTOR—breast cancer	3.26e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CB—breast cancer	3.26e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1B—breast cancer	3.26e-06	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD4—breast cancer	3.26e-06	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—breast cancer	3.24e-06	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—breast cancer	3.24e-06	2.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—breast cancer	3.23e-06	2.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGF—breast cancer	3.23e-06	2.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—breast cancer	3.18e-06	1.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—breast cancer	3.18e-06	1.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—breast cancer	3.17e-06	1.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—breast cancer	3.16e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—breast cancer	3.16e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—breast cancer	3.15e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—breast cancer	3.13e-06	1.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FN1—breast cancer	3.11e-06	1.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—breast cancer	3.1e-06	1.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—breast cancer	3.1e-06	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—breast cancer	3.09e-06	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—breast cancer	3.08e-06	1.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NFKBIA—breast cancer	3.08e-06	1.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—breast cancer	3.07e-06	1.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1B—breast cancer	3.06e-06	1.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—breast cancer	3.06e-06	1.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—breast cancer	3.05e-06	1.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—breast cancer	3.05e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH1—breast cancer	3.05e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—breast cancer	3.04e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—breast cancer	3.04e-06	1.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—breast cancer	3.02e-06	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—breast cancer	2.99e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1—breast cancer	2.99e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT2—breast cancer	2.99e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK8—breast cancer	2.99e-06	1.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—breast cancer	2.98e-06	1.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—breast cancer	2.98e-06	1.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—breast cancer	2.98e-06	1.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGF—breast cancer	2.95e-06	1.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK3—breast cancer	2.91e-06	1.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—breast cancer	2.9e-06	1.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—breast cancer	2.89e-06	1.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CD—breast cancer	2.87e-06	1.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—breast cancer	2.87e-06	1.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK3—breast cancer	2.86e-06	1.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SERPINE1—breast cancer	2.84e-06	1.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—breast cancer	2.83e-06	1.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—breast cancer	2.83e-06	1.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—breast cancer	2.83e-06	1.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—breast cancer	2.82e-06	1.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—breast cancer	2.82e-06	1.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—breast cancer	2.81e-06	1.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—breast cancer	2.8e-06	1.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—breast cancer	2.77e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—breast cancer	2.76e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—breast cancer	2.73e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1—breast cancer	2.73e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT2—breast cancer	2.73e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—breast cancer	2.72e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOS3—breast cancer	2.71e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK3—breast cancer	2.64e-06	1.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CD—breast cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—breast cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—breast cancer	2.61e-06	1.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK3—breast cancer	2.61e-06	1.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SERPINE1—breast cancer	2.59e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—breast cancer	2.57e-06	1.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—breast cancer	2.57e-06	1.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—breast cancer	2.57e-06	1.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAF1—breast cancer	2.57e-06	1.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—breast cancer	2.56e-06	1.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RELA—breast cancer	2.55e-06	1.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—breast cancer	2.54e-06	1.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—breast cancer	2.52e-06	1.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—breast cancer	2.51e-06	1.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CB—breast cancer	2.5e-06	1.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MTOR—breast cancer	2.5e-06	1.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—breast cancer	2.48e-06	1.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOS3—breast cancer	2.47e-06	1.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK3—breast cancer	2.41e-06	1.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—breast cancer	2.41e-06	1.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—breast cancer	2.41e-06	1.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—breast cancer	2.37e-06	1.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—breast cancer	2.36e-06	1.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1B—breast cancer	2.35e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—breast cancer	2.35e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—breast cancer	2.34e-06	1.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—breast cancer	2.34e-06	1.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAF1—breast cancer	2.34e-06	1.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—breast cancer	2.34e-06	1.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RELA—breast cancer	2.33e-06	1.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—breast cancer	2.33e-06	1.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—breast cancer	2.31e-06	1.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—breast cancer	2.3e-06	1.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—breast cancer	2.3e-06	1.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—breast cancer	2.29e-06	1.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CB—breast cancer	2.28e-06	1.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MTOR—breast cancer	2.28e-06	1.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—breast cancer	2.24e-06	1.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—breast cancer	2.24e-06	1.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—breast cancer	2.23e-06	1.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—breast cancer	2.22e-06	1.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—breast cancer	2.19e-06	1.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—breast cancer	2.18e-06	1.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—breast cancer	2.18e-06	1.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—breast cancer	2.18e-06	1.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—breast cancer	2.17e-06	1.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—breast cancer	2.16e-06	1.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—breast cancer	2.16e-06	1.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—breast cancer	2.15e-06	1.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1B—breast cancer	2.14e-06	1.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—breast cancer	2.13e-06	1.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK8—breast cancer	2.12e-06	1.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—breast cancer	2.1e-06	1.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—breast cancer	2.1e-06	1.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—breast cancer	2.09e-06	1.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—breast cancer	2.04e-06	1.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—breast cancer	2.04e-06	1.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—breast cancer	2.03e-06	1.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—breast cancer	2.02e-06	1.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—breast cancer	2.01e-06	1.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—breast cancer	1.99e-06	1.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—breast cancer	1.99e-06	1.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—breast cancer	1.99e-06	1.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—breast cancer	1.98e-06	1.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—breast cancer	1.97e-06	1.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—breast cancer	1.97e-06	1.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—breast cancer	1.95e-06	1.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—breast cancer	1.94e-06	1.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK8—breast cancer	1.93e-06	1.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—breast cancer	1.93e-06	1.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—breast cancer	1.93e-06	1.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—breast cancer	1.91e-06	1.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK3—breast cancer	1.85e-06	1.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—breast cancer	1.84e-06	1.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—breast cancer	1.83e-06	1.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—breast cancer	1.8e-06	1.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—breast cancer	1.79e-06	1.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—breast cancer	1.78e-06	1.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—breast cancer	1.78e-06	1.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—breast cancer	1.77e-06	1.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—breast cancer	1.76e-06	1.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—breast cancer	1.76e-06	1.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—breast cancer	1.76e-06	1.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK3—breast cancer	1.69e-06	1.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—breast cancer	1.66e-06	1.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—breast cancer	1.64e-06	1.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—breast cancer	1.64e-06	1.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—breast cancer	1.62e-06	1.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—breast cancer	1.6e-06	9.96e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—breast cancer	1.53e-06	9.48e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—breast cancer	1.52e-06	9.41e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—breast cancer	1.48e-06	9.17e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—breast cancer	1.41e-06	8.77e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—breast cancer	1.39e-06	8.65e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—breast cancer	1.35e-06	8.4e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—breast cancer	1.35e-06	8.37e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—breast cancer	1.29e-06	8e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—breast cancer	1.25e-06	7.75e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—breast cancer	1.23e-06	7.66e-06	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—breast cancer	1.14e-06	7.06e-06	CbGpPWpGaD
